Use access key #2 to skip to page content.
$0.50 -0.11 (-18.03%)
10/6/2008 4:00 PM

Hana Biosciences, Inc. (HNAB)

CAPS Rating:
No stars

A development stage biopharmaceutical company focused on acquiring, developing, and commercializing innovative products to advance cancer care.

View All Commentary (HNAB)

Recs

1

Avatar fullwealth (94.40) Submitted: 3/05/07 12:21 PM : Outperform Start Price: $3.93 HNAB Score: -62.89

ride the index back up

Report this Post Replies: 0 | Reply

Featured Broker Partners